|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2010-2-22
|
|
pubmed:abstractText |
Cytomegalovirus (CMV) is a major cause of graft failure and posttransplantation mortality in intestinal/multivisceral transplantation. CMV infection exhibits a wide range of clinical manifestations from asymptomatic infection to severe CMV disease. STUDY'S PURPOSE: The purposes of this study were to assess the utility of measuring CMV-specific cellular immunity in bowel/multivisceral transplant recipients and to provide additional information on the risk of infection and development of CMV disease.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal, Humanized,
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Neoplasm,
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Ganciclovir,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulins,
http://linkedlifedata.com/resource/pubmed/chemical/Immunosuppressive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Tacrolimus,
http://linkedlifedata.com/resource/pubmed/chemical/alemtuzumab
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1873-2623
|
|
pubmed:author |
pubmed-author:BaccoliniFF,
pubmed-author:CesconMM,
pubmed-author:ChiereghinAA,
pubmed-author:DazziAA,
pubmed-author:GabrielliLL,
pubmed-author:LandiniM PMP,
pubmed-author:LauroAA,
pubmed-author:LazzarottiRR,
pubmed-author:MorelliM CMC,
pubmed-author:PetrisliEE,
pubmed-author:PiccirilloMM,
pubmed-author:PinnaA DAD,
pubmed-author:ZanfiCC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
69-73
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:20172283-Adult,
pubmed-meshheading:20172283-Antibodies, Monoclonal,
pubmed-meshheading:20172283-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:20172283-Antibodies, Neoplasm,
pubmed-meshheading:20172283-Antiviral Agents,
pubmed-meshheading:20172283-Cytomegalovirus,
pubmed-meshheading:20172283-Cytomegalovirus Infections,
pubmed-meshheading:20172283-Female,
pubmed-meshheading:20172283-Ganciclovir,
pubmed-meshheading:20172283-Humans,
pubmed-meshheading:20172283-Immunity, Cellular,
pubmed-meshheading:20172283-Immunoglobulins,
pubmed-meshheading:20172283-Immunosuppressive Agents,
pubmed-meshheading:20172283-Intestine, Small,
pubmed-meshheading:20172283-Male,
pubmed-meshheading:20172283-Monitoring, Immunologic,
pubmed-meshheading:20172283-Postoperative Complications,
pubmed-meshheading:20172283-Retrospective Studies,
pubmed-meshheading:20172283-T-Lymphocytes,
pubmed-meshheading:20172283-Tacrolimus,
pubmed-meshheading:20172283-Viscera
|
|
pubmed:articleTitle |
Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients.
|
|
pubmed:affiliation |
St. Orsola Malpighi General Hospital, University of Bologna, Bologna, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
